ArticleBMC microbiology2026
Comprehensive genomic characterization and public health implications of multidrug-resistant Escherichia coli from poultry in Noakhali, Bangladesh.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Emerging zoonotic risks: whole-genome sequencing reveals antimicrobial resistance and genomic diversity in Providencia stuartii isolated from broiler chickens in Noakhali, Bangladesh.Poultry science · 2026Article
- Mobilome-driven antimicrobial resistance in a one health context: evidence and lessons from Africa.Frontiers in veterinary science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionPoultry chickens and their farming environments serve as reservoirs for multi-drug resistant (MDR) pathogenic Escherichia coli (E. coli) that can spread to other species, including humans. In response to this, the study was conducted to assess the antibiotic resistance profile, virulence capabilities, and zoonotic potential of isolates obtained from poultry chickens in Noakhali, Bangladesh.
methodsE. coli isolates were identified through biochemical and molecular methods, including 16S rRNA sequencing. After antibiotic susceptibility testing and multiple antibiotic resistance index (MARI) profiling, two strains out of twenty-four underwent whole-genome Illumina sequencing. For the genetic characterization of these two isolates, genome annotation, serotyping, multilocus sequence typing (MLST), fimbrial typing, plasmid profiling, identification of resistance and virulence genes, detection of mobile genetic elements (MGEs), pan-genome analysis, and phylogenetic comparison were performed.
resultsThe two sequenced strains (one lactose-negative and the other lactose-positive) exhibited resistance to nearly all of the 17 tested antibiotics, with a MAR index of 0.82. Both strains contained ~ 58 AMR genes, including significant genes like blaTEM-1B, qnrS1, aac(3)IId, tet(A), dfrA1, and sul3. Each strain carried six plasmids, including a novel one, along with multiple metal resistance genes (MRGs) that conferred tolerance to arsenic, tellurium, copper, and silver, indicating their ability to survive in metal-rich environments. Pathogenicity prediction suggested a 91.4% probability of causing human infection. Virulence genes related to adhesion, biofilm formation, and immune evasion were identified. Comparative genomics showed similarity to clinical strains.
conclusionAlthough zoonotic transmission was not directly evaluated, genomic similarity and the presence of human-associated virulence and AMR genes suggest a potential public health risk from poultry strains. These findings highlight the zoonotic threat posed by MDR bacteria in poultry farms. Regular monitoring of antibiotic use in poultry, along with genomic surveillance of MDR isolates, is crucial to mitigate this emerging public health concern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.